Ruzotolimod 是TLR7的激动剂。Ruzotolimod 具有研究 HBV、COVID-19 或 SARS-CoV-2 感染的潜力 (信息提取自专利 WO2021130195A1)。
| 生物活性 | Ruzotolimod is the agonist ofTLR7. Ruzotolimod has the potential for the research ofHBV, COVID-19 or SARS-CoV-2infection(extracted from patent WO2021130195A1)[1]. |
| IC50& Target | |
| 分子量 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com
